Omnicom, CAHG sign up for regulatory compliance training

Share this article:
Agency CAHG became the first healthcare marketing shop to undergo training and certification in regulatory compliance through the Center for Communication Compliance, and its parent company, Omnicom, said all of its healthcare agencies will follow suit.

More than half of CAHG's staff will be required to undergo annual training as a condition for employment, which has offices in Chicago and New York. That includes all client-facing staff “in a direct position to influence deliverables for clients,” said CEO Scott Cotherman.

“As there's increasing scrutiny over the development of materials in support of our clients' products and services, we feel responsibility to take a leadership position so that our clients have the confidence that we are able to provide them with the level of service they expect,” said Cotherman. “Innovation and risk mitigation are often at odds with each other, but it's our responsibility to deliver the greatest possible innovation during a time of increased regulatory scrutiny.”

Tom Harrison, who heads Omnicom's Diversified Agency Services unit, which includes the company's healthcare businesses, said the firm is looking to get out in front of anticipated demand for such training, though not many clients are asking for it yet.

“We are being proactive in that we are certainly expecting most of our clients to demand this as a cost of doing business for and with them,” said Harrison. “It will make us more valuable communications partners. It is vital that clients' agency partners be in tune and fully versed on the regulations as we develop communications strategies for our clients and their brands.”

The New York-based Center for Communication Compliance's training consists of three one-hour modules covering the regulatory environment and the how-to of tactical execution, followed by a test.
Share this article:
You must be a registered member of MMM to post a comment.

Email Newsletters

MM&M Future Leaders


Register now

Early bird $1,950 before 31 October 2014

*Group discounts available on request 

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Channel

Five things for pharma marketers to know: Monday, September 15

Five things for pharma marketers to know: ...

Pharma has sought 76 meetings with FDA over biosimilars; Gilead licenses Sovaldi to India generic drugmakers; Pfizer and Ranbaxy Lipitor lawsuit dismissed.

Liraglutide, aiming for new indication, gets new name

Liraglutide, aiming for new indication, gets new name

Why Novo Nordisk is choosing not to leverage Victoza's brand equity as it seeks a weight-loss indication for liraglutide.

Five things for pharma marketers to know: Friday, September 12

Five things for pharma marketers to know: Friday, ...

An FDA panel voted in favor of liraglutide for weight loss; Allergan investors backing an attempted takeover of the firm crossed a critical threshold; and 100 million health wearables are ...